Log in

Roche acquires mySugr Diabetes Management Platform

The Swiss pharmaceutical group Roche will buy all the shares of mySugr, a platform for mobile diabetes management services, announced Friday without disclosing the amount of the transaction.

The acquisition will allow Roche to strengthen its management of this disease, the group plans to establish an open platform of digital services for the management of diabetes, he said in a statement.

"MySugr being our partner since 2014, we believe that the cultural fit is excellent," said Roland Diggelmann, CEO of Roche Diagnostics, quoted in the statement.

"Our goal is to help these patients spend more time in their ideal target blood glucose range," he added.

Founded in 2012, mySugr GmbH offers applications and services that simplify the treatment of diabetes through smartphones.

Available in 52 countries in 13 languages, its platform has more than one million users worldwide.

The company employs 47 people in its offices in Vienna and San Diego, California.

a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb - drapeauitalie )

  group    administrators A3P
& Project Managers

letter   newsletter A3P